329 related articles for article (PubMed ID: 4605566)
21. The combined use of clofibrate and anion exchange in the treatment of hypercholesterolemia.
Howard AN; Hyams DE; Evans C
Adv Exp Med Biol; 1972; 26(0):179-87. PubMed ID: 4679724
[No Abstract] [Full Text] [Related]
22. [Cholestyramine as a cholesterol lowering preparation. A clinical evaluation].
Bye A; Brox D
Tidsskr Nor Laegeforen; 1976 Jun; 96(16):928-9. PubMed ID: 779134
[No Abstract] [Full Text] [Related]
23. [Is hypolipemic treatment effective as a preventive measure?].
Rywik S
Przegl Lek; 1989; 46(7):619-23. PubMed ID: 2685917
[No Abstract] [Full Text] [Related]
24. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
Huth K; Blumenthal J; Schmahl FW
Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868
[No Abstract] [Full Text] [Related]
25. Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
Islami Y; Ribeiro LG
Arq Bras Cardiol; 1988 Jul; 51(1):43-8. PubMed ID: 3073735
[No Abstract] [Full Text] [Related]
26. Diet and drug therapy for hyperlipoproteinemia.
Maha GE
Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828
[No Abstract] [Full Text] [Related]
27. Therapy of the hyperlipoproteinemias.
Bagdade JD
Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():98-110. PubMed ID: 4605376
[No Abstract] [Full Text] [Related]
28. The primary hyperlipoproteinemias.
Bybee DE; Hamilton RD
J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
[No Abstract] [Full Text] [Related]
29. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
[No Abstract] [Full Text] [Related]
30. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
Therapie; 1978; 33(5):615-22. PubMed ID: 217121
[No Abstract] [Full Text] [Related]
31. [Treatment of hypercholesteremia with cholestyramine].
Jacotot B; Beaumont V; Buxtorf JC; Le Parco JC; Beaumont JL
Therapeutique; 1972 Mar; 48(3):225-30. PubMed ID: 4560997
[No Abstract] [Full Text] [Related]
32. [Hyperlipoproteinemias: significance--diagnosis--therapy].
Schwandt P
Internist (Berl); 1971 Nov; 12(11):481-7. PubMed ID: 4943880
[No Abstract] [Full Text] [Related]
33. Treatment of hypercholesterolemia.
Kane JP; Havel RJ
Annu Rev Med; 1986; 37():427-35. PubMed ID: 3518611
[No Abstract] [Full Text] [Related]
34. [Vasosan S--a cholestyramine in the treatment of hypercholesterolemia of various etiopathogenesis].
Kolesár P
Vnitr Lek; 1994 Feb; 40(2):89-92. PubMed ID: 8140767
[TBL] [Abstract][Full Text] [Related]
35. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
Bavina MV; Perova NV; Lobova NM; Koropova GI
Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180
[No Abstract] [Full Text] [Related]
36. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
[TBL] [Abstract][Full Text] [Related]
37. Surgical treatment of hyperlipidemia. I. Apologia.
Buchwald H; Moore RB; Varco RL
Circulation; 1974 May; 49(5 Suppl):I1-12. PubMed ID: 4596500
[No Abstract] [Full Text] [Related]
38. Hypolipaemic drugs and coronary heart disease.
Howard AN
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
[No Abstract] [Full Text] [Related]
39. Drug treatment of hyperlipidemia.
Spector AA
J Iowa Med Soc; 1972 Oct; 62(10):524-5 passim. PubMed ID: 5074337
[No Abstract] [Full Text] [Related]
40. Hypolipidemic drugs and hyperlipoproteinemia.
Levy RI; Langer T
Ann N Y Acad Sci; 1971 Jul; 179():475-80. PubMed ID: 4941915
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
